Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3897111012 | Product containing ubrogepant (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3897112017 | Ubrogepant-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing ubrogepant (medicinal product) | Is a | Medicinal product acting as antimigraine agent (product) | true | Inferred relationship | Existential restriction modifier | ||
Product containing ubrogepant (medicinal product) | Plays role | Antimigraine therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing ubrogepant (medicinal product) | Is a | Medicinal product categorized by structure | true | Inferred relationship | Existential restriction modifier | ||
Product containing ubrogepant (medicinal product) | Is a | Product containing calcitonin gene-related peptide receptor antagonist (product) | true | Inferred relationship | Existential restriction modifier | ||
Product containing ubrogepant (medicinal product) | Has active ingredient | Ubrogepant | true | Inferred relationship | Existential restriction modifier | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing only ubrogepant (medicinal product) | Is a | True | Product containing ubrogepant (medicinal product) | Inferred relationship | Existential restriction modifier | |
Product containing ubrogepant in oral dose form (medicinal product form) | Is a | True | Product containing ubrogepant (medicinal product) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets